Cited by

• Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.

  Qu C, Chen T, Fan C, Zhan Q, Wang Y, Lu J, Lu LL, Ni Z, Huang F, Yao H, Zhu J, Fan J, Zhu Y, Wu Z, Liu G, Gao W, Zang M, Wang D, Dai M, Hsia CC, Zhang Y, Sun Z. Qu C, et al. PLoS Med. 2014 Dec 30;11(12):e1001774. doi: 10.1371/journal.pmed.1001774. eCollection 2014 Dec. PLoS Med. 2014. PMID: 25549238 Free PMC article. Clinical Trial.
• Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.

  Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, Lu P, Hsia CC, Wang N, Xu L, Lu L, Huang F, Zhu Y, Lu J, Ni Z, Zhang Q, Wu Y, Liu G, Wu Z, Qu C, Gail MH. Sun Z, et al. Carcinogenesis. 2013 Aug;34(8):1800-5. doi: 10.1093/carcin/bgt007. Epub 2013 Jan 14. Carcinogenesis. 2013. PMID: 23322152 Free PMC article.
• Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children.

  Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A. Whittle H, et al. BMJ. 2002 Sep 14;325(7364):569. doi: 10.1136/bmj.325.7364.569. BMJ. 2002. PMID: 12228132 Free PMC article.
• Cellular DNA content and histopathological analysis in hepatocellular carcinoma with multiple nodules.

  Ichikawa N, Fujimoto J, Okamoto E, Yamanaka N, Nishigami T. Ichikawa N, et al. Surg Today. 1997;27(6):483-90. doi: 10.1007/BF02385799. Surg Today. 1997. PMID: 9306539
• Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients.

  Lo YM, Lo ES, Mehal WZ, Sampietro M, Fiorelli G, Ronchi G, Tse CH, Fleming KA. Lo YM, et al. J Clin Pathol. 1993 Apr;46(4):304-8. doi: 10.1136/jcp.46.4.304. J Clin Pathol. 1993. PMID: 8496385 Free PMC article.